Key terms

About WBA

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest WBA news

May 16 4:08am ET Hold Rating on Walgreens Boots Alliance Amid Potential Sale of Boots Segment and Financial Implications May 15 8:10am ET Walgreens brand Naloxone available online and in stores in May May 14 7:26am ET TD Cowen Reaffirms Their Buy Rating on Walgreens Boots Alliance (WBA) May 13 9:57am ET Walgreens working with advisers on Boots sale, Bloomberg reports May 13 9:55am ET Early notable gainers among liquid option names on May 13th May 13 9:54am ET Walgreens jumps 6% to $18.29 after Bloomberg report of Boots sale process May 13 9:54am ET Walgreens contacts potential buyers of Boots chain, Bloomberg says May 01 5:12pm ET Walgreens Boots Alliance Nears Shareholder Suit Settlement May 01 12:45pm ET CVS Health downgraded to Market Perform from Outperform at Leerink Apr 24 9:05am ET DoorDash, Walgreens Boots Alliance announce collaboration to offer SNAP/EBT Apr 17 5:10am ET Analysts Offer Insights on Healthcare Companies: Walgreens Boots Alliance (WBA), Ocular Therapeutix (OCUL) and Elevance Health (ELV) Apr 15 7:20am ET Analysts Offer Insights on Healthcare Companies: Bausch Health Companies (BHC), Walgreens Boots Alliance (WBA) and Evolent Health (EVH) Apr 12 12:33pm ET Walgreens Boots Alliance participates in a conference call with JPMorgan Apr 08 5:49am ET Buy Rating Affirmed for Walgreens Amid Strategic Financial Restructuring and Management Optimism Apr 03 3:31pm ET Walgreens disclosed $2.7B tax liability from IRS, says UBS Apr 03 9:16am ET Walgreens Boots Alliance price target lowered to $22 from $23 at Deutsche Bank Apr 03 7:28am ET Walgreens Boots Alliance price target lowered to $35 from $37 at TD Cowen Apr 02 6:26am ET Walgreens Stock (NASDAQ:WBA): Tax Concerns Overblown, Says Analyst Apr 01 7:21am ET Truist Financial Sticks to Its Hold Rating for Walgreens Boots Alliance (WBA) Apr 01 3:40am ET Analysts Offer Insights on Healthcare Companies: OptimizeRx (OPRX), Walgreens Boots Alliance (WBA) and Kodiak Sciences (KOD) Mar 31 4:09pm ET Walgreens Boots Alliance price target lowered to $20 from $21 at Morgan Stanley Mar 30 5:02am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Walgreens Boots Alliance (WBA), DiaSorin S.p.A. (GB:0GZX) and Novozymes (GB:0Q4U) Mar 28 6:27pm ET Walgreens Boots Alliance CEO: We’re focused on improving front end of the store Mar 28 5:13pm ET Walgreens Announces Executive Leadership Transition and Consultancy Mar 28 9:41am ET Unusually active option classes on open March 28th Mar 28 8:07am ET WBA Earnings: Walgreens Tanks on Narrowed Outlook Mar 28 8:05am ET Options Volatility and Implied Earnings Moves Today, March 28, 2024 Mar 28 7:32am ET Walgreens Boots Alliance Q1 Earnings Call and Insights Mar 28 7:12am ET Walgreens narrows FY24 adjusted EPS view to $3.20-$3.25 from $3.20-$3.50 Mar 28 7:05am ET Walgreens Boots Alliance reports Q2 adjusted EPS $1.20, consensus 82c Mar 27 8:25pm ET Notable companies reporting before tomorrow’s open

WBA Financials

1-year income & revenue

Key terms

WBA Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

WBA Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms